Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo.

Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo.

Item
http://www.wikidata.org/entity/Q38764048
Galectin-1-based tumour-targeting for gold nanostructure-mediated photothermal therapy.Suppression of Retinal Neovascularization by Inhibition of Galectin-1 in a Murine Model of Oxygen-Induced Retinopathy.Serum galectin-1 in patients with multiple myeloma: associations with survival, angiogenesis, and biomarkers of macrophage activation.Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formationLenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory propertiesRole of Galectins in Multiple Myeloma.Proteomic characterization of human multiple myeloma bone marrow extracellular matrix.Treatment of B-cell precursor acute lymphoblastic leukemia with the Galectin-1 inhibitor PTX008.Extracellular galectins as controllers of cytokines in hematological cancer
P2860

Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo.

Item
http://www.wikidata.org/entity/Q38764048
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Galectin-1 suppression delinea ...... is and tumoral growth in vivo.
@en
type
label
Galectin-1 suppression delinea ...... is and tumoral growth in vivo.
@en
prefLabel
Galectin-1 suppression delinea ...... is and tumoral growth in vivo.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698
P356
P1433
P1476
Galectin-1 suppression delinea ...... is and tumoral growth in vivo.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698